Document Detail


Involvement of resistance to apoptosis in the pathogenesis of endometriosis.
MedLine Citation:
PMID:  19609865     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endometriosis, a disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue. Increasingly, endometriosis is also becoming recognized as a condition in which ectopic endometrial cells exhibit abnormal proliferative and apoptotic regulation in response to appropriate stimuli. Apoptosis plays a critical role in maintaining tissue homeostasis and represents a normal function to eliminate excess or dysfunctional cells. Accumulated evidence suggests that, in healthy women, endometrial cells expelled during menstruation do not survive in ectopic locations because of programmed cell death, while decreased apoptosis may lead to the ectopic survival and implantation of these cells, resulting in the development of endometriosis. Both the inability of endometrial cells to transmit a 'death' signal and the ability of endometrial cells to avoid cell death have been associated with increased expression of anti-apoptotic factors and decreased expression of pre-apoptotic factors. This paper is a review of the recent literature focused on the differential expression of apoptosis-associated molecules in the normal endometria of women without endometriosis, and in the eutopic and ectopic endometria of women with endometriosis. The role of apoptosis in the pathogenesis of endometriosis and the basic and clinical research on the current medical treatment for endometriosis from the view of apoptosis will be discussed.
Authors:
K Nasu; A Yuge; A Tsuno; M Nishida; H Narahara
Related Documents :
4373395 - Induction of interferon in mice by mycoplasmas.
19081025 - Hypertonic saline resuscitation from hemorrhagic shock does not impair the neutrophil r...
11949945 - Regulation and modulation of abnormal immune responses in endometriosis.
6966615 - Depressed immunological defence mechanisms in mice with experimentally induced diabetes.
21728175 - Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autorea...
20536465 - Preclinical studies with irx-2 and thymosin alpha1 in combination therapy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Histology and histopathology     Volume:  24     ISSN:  1699-5848     ISO Abbreviation:  Histol. Histopathol.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-07-17     Completed Date:  2009-10-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8609357     Medline TA:  Histol Histopathol     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  1181-92     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Oita, Japan. nasu@med.oita-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis* / genetics,  physiology
Aromatase Inhibitors / therapeutic use
Danazol / therapeutic use
Drug Resistance / genetics*
Endometriosis / drug therapy,  etiology*,  pathology*
Endometrium / cytology*,  drug effects
Estrogen Antagonists / therapeutic use
Female
Gonadotropin-Releasing Hormone / agonists
Humans
Progesterone / therapeutic use
Chemical
Reg. No./Substance:
0/Aromatase Inhibitors; 0/Estrogen Antagonists; 17230-88-5/Danazol; 33515-09-2/Gonadotropin-Releasing Hormone; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polarized endocytic transport: the roles of Rab11 and Rab11-FIPs in regulating cell polarity.
Next Document:  A review of ERGIC-53: its structure, functions, regulation and relations with diseases.